Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Københavns Universitets forskningsportal Forside
Hjælp og OSS
Dansk
English
Forside
Profiler
Publikation
Forskningsenheder
Presse/medier
Aktiviteter
Priser
???studenttheses???
Forskningsdatasæt
Søg efter ekspertise, navn eller tilknytning
Investigational drugs in clinical trials for Hidradenitis Suppurativa
Peter Theut Riis
*
, Linnea R. Thorlacius,
Gregor B. Jemec
*
Corresponding author af dette arbejde
Institut for Klinisk Medicin
25
Citationer (Scopus)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'Investigational drugs in clinical trials for Hidradenitis Suppurativa'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Keyphrases
Investigational Drugs
100%
Clinical Trials
100%
Hidradenitis Suppurativa
100%
Phase I Trial
50%
Hidradenitis
50%
Phase II Trial
50%
New Drugs
25%
Meta-analysis
25%
Botulinum Toxin B
25%
Expert Opinion
25%
Unmet Medical Need
25%
Clinical Response
25%
Phosphodiesterase 4 Inhibitor
25%
Triamcinolone Acetonide
25%
New Treatment Options
25%
Interleukin-17 (IL-17)
25%
EudraCT
25%
Benzoyl Peroxide
25%
Clinical Trial Registry
25%
Area Cover
25%
Treatment Options
25%
Interleukin-1β
25%
Adalimumab
25%
Targets for Therapy
25%
Chronic Skin Disease
25%
Randomized Controlled Trial
25%
Metformin
25%
Medicine and Dentistry
Clinical Trial
100%
Hidradenitis Suppurativa
100%
Investigational Drug
100%
Phase II Trials
50%
Hidradenitis
50%
Phase I Trials
50%
Meta-Analysis
25%
Adalimumab
25%
Interleukin 1
25%
Phosphodiesterase IV Inhibitor
25%
Randomized Controlled Trial
25%
Interleukin 17
25%
Dermatosis
25%
Glycon
25%
Immunosuppressant
25%
Triamcinolone
25%
Pharmacology, Toxicology and Pharmaceutical Science
Suppurative Hidradenitis
100%
Clinical Trial
100%
Investigational Drug
100%
Phase I Trials
50%
Phase II Trials
50%
Randomized Controlled Trial
25%
Interleukin 1
25%
Immunosuppressive Agent
25%
Botulinum Toxin B
25%
Triamcinolone
25%
Secukinumab
25%
Skin Disease
25%
Phosphodiesterase IV Inhibitor
25%
Metformin
25%
Interleukin 17
25%
Adalimumab
25%
Benzoyl Peroxide
25%